T
Overview
TurnCare develops B2B healthcare technology for high-acuity patients. Its Guardian System uses VasoTactic to apply dynamic pressure gradients on the sacral region via an inflatable surface, controller, and real-time dashboard to prevent pressure injuries and improve mobility. It differentiates itself with patented pressure-management technology and data-driven insights, along with a usage-based payment model arranged with Monetize360. The goal is to reduce hospital-acquired pressure injuries, shorten stays, and improve patient safety and throughput in acute care settings.
Work here?Claim your company
Simplify's take
What believers are saying
- TurnCare presented new real-world ECMO data at ELSO 2026.
- May 2026 ISPOR evidence strengthened pressure-injury economics for purchasing teams.
- John F. Milligan joined the board in January 2024, boosting credibility.
What critics are saying
- FDA MAUDE logged a Guardian 2 pressure sore event in April 2025.
- TurnCare raised only $10.2 million, last disclosed in November 2019.
- Nine open jobs signal commercialization pressure; failure to scale sales stalls survival.
What makes TurnCare unique
- Guardian System combines pressure relief hardware, software, and real-time operational insights.
- TurnCare’s VasoTactic algorithm targets sacral perfusion during high-acuity immobility.
- Usage-based hospital billing through Monetize360 lowers adoption friction versus upfront device sales.
Help us improve and share your feedback! Did you find this helpful?